Alzheimer's | |||||
NEWS | |||||
UConn Patents Novel Combination Approach for Alzheimer's Treatment These peptides form plaques and are thought to cause the onset and progression of Alzheimer's Disease. The obvious solution would seem to be ...
| |||||
Memory Treatment Centers is One of First to Administer Aduhelm Alzheimer's Infusion This groundbreaking drug, developed by Biogen, slows cognitive decline by reducing amyloid beta plaque in the brain – a hallmark of Alzheimer's ...
| |||||
Cortexyme Provides Business Update and Reports Second Quarter 2021 Results GAIN Trial top-line data for disease modification in Alzheimer's expected by mid-November 2021. Phase 2 REPAIR sub-study results evaluating ...
| |||||
What to Do After Cassava Sciences Dropped Off a Cliff It detects Alzheimer's disease through a blood test. In the Phase 2b study, Cassava said, "simufilam significantly reduced plasma levels of altered filamin ...
| |||||
Machine learning plus insights from genetic research shows the workings of cells Our approach works across a broad range of cell types and organs and could be used to develop treatments for diseases like COVID-19 or Alzheimer's.
| |||||
UBNow "Photobiomodulation therapy has been effectively used in supportive cancer care, age-related macular degeneration and Alzheimer's disease," says ...
| |||||
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business ... ... activity being developed for the following indications: major depressive disorder (MDD), Alzheimer's disease (AD) agitation, and smoking cessation.
| |||||
WEB | |||||
Neurodegeneration, Alzheimer's disease, and beta-amyloid toxicity - ScienceDirect In its majority, Alzheimer's disease is sporadic and with late onset. Therefore, age-related disturbances in cellular metabolism may come into focus ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |